You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國再生醫學(08158.HK)擬折讓約10.71%增發2.3億股
格隆匯 10-08 20:54

格隆匯 10 月 8日丨中國再生醫學(08158.HK)公告,於2020年10月8日,公司及附屬公司(公司全資附屬公司)分別與服務供應商訂立認購及清償協議,據此,公司有條件同意發行,而服務供應商有條件同意或促使其各自代名人以發行價每股認購股份0.20港元認購合共2.3億股認購股份。

服務供應商將於完成時透過抵銷附屬公司結欠服務供應商應付賬款支付認購價,而公司將向服務供應商配發及發行認購股份,作為應付賬款全數及最終結付。發行價為每股認購股份0.20港元,較10月8日公司收市價每股0.224港元折讓約10.71%。

認購股份將於各方面與現有股份享有同等地位,將根據一般授權配發及發行。公司將向聯交所GEM上市委員會申請批准認購股份上市及買賣。

於公告日期,公司尚未根據一般授權配發及發行任何股份,而一般授權足以配發及發行所有認購股份。因此,配發及發行認購股份毋須獲股東進一步批准。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account